Phase 2a TREE study assesses safety and efficacy of leriglitazone
Company seeks new direction after negative CHMP opinion on KIZFIZO
Updated Date: Tue, 04 Mar 2025 00:00:00 EST
CervoMed’s therapy demonstrates significant improvement in patients
Researchers were shocked to see that bacteria’s antimicrobial resistance is strengthened when exposed to plastic particles and point […]
Oxford Medical Products targets overweight individuals
The herb rosemary has long been linked with memory: ‘There’s rosemary, that’s for remembrance,’ says Ophelia in Shakespeare’s […]
Updated Date: Mon, 03 Mar 2025 00:00:00 EST
Updated Date: Mon, 03 Mar 2025 00:00:00 EST
FSCD therapy meets all endpoints in interim analysis